Cancer patients in India are set to benefit from significant reductions in treatment costs after the National Cancer Grid (NCG) negotiated discounts of up to 85% for bulk procurement of essential cancer medicines. The discounts, applicable to 50 NCG member hospitals, cover chemotherapy drugs, targeted therapies, supportive care medications, antibiotics, antifungals, and over 260 other essential medicines. This initiative not only reduces out-of-pocket expenses for patients but also ensures that smaller hospitals and remote areas receive timely supplies of high-quality drugs.

Key highlightsGroup procurement to reduce treatment costs

• Bulk purchase negotiations with pharma companies allow NCG hospitals to buy essential drugs at up to 85% lower prices.

• Covers medications required for chemotherapy, targeted therapy, supportive care, antibiotics, antifungals, and more.

• Over 200 types of medicines are now available at discounted rates across the 50 member hospitals.

Wider access for remote and smaller hospitals

• Bulk supply ensures smaller hospitals and remote regions are no longer deprived of high-cost medicines.

• Addresses prior reluctance from companies to supply medicines to rural and smaller hospitals.

• Patients with advanced-stage cancers benefit from uninterrupted drug availability.

Positive impact on hospitals and patients

• Cost savings free up hospital funds for other critical initiatives.

• Reduces delays in treatment and prevents stockouts in remote centres.

• Charitable hospitals and patient aid associations can now provide affordable care to more patients.

Patient and expert reactions

• Dr. C.S. Pramesh, NCG convenor, emphasizes timely access and sustainability of cancer treatment.

• Dr. Sangeeta Mudaliar (BJ Wadia Hospital) highlights chemotherapy cost reduction as a major benefit.

• Alka S Bisen (Cancer Patients Aid Association) notes that lower drug prices ease the financial burden on families and improve access to care.

The NCG’s group procurement initiative represents a landmark effort in making cancer treatment more affordable and accessible across India. By lowering drug costs, ensuring timely supply to member hospitals, and extending reach to rural areas, the scheme promises to improve patient outcomes and reduce the financial strain on families. This collective effort marks a significant step toward equitable and sustainable cancer care in India.